Vasculitis
Vasculitis is a condition within the immune-health category. Its classification provides a framework for understanding where it fits, while surrounding information offers essential context.
See where Vasculitis fits within immune health and get essential context in one place.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
1 option:1 no benefit found
Cupping TherapypracticeNo benefit found
Studies looked for a benefit and did not find one.
The one study found no benefit.
The reported studies did not support cupping for vasculitis: a 2021 review described one case report of benefit for superficial thrombotic phlebitis and another reporting bullous lesions after cupping.
Open the Cupping Therapy page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedThe best we have, but the evidence is still weak
- →PracticesCupping TherapyCertaintyVery lowSourceReview
The reported studies did not support cupping for vasculitis: a 2021 review described one case report of benefit for superficial thrombotic phlebitis and another reporting bullous lesions after cupping.
Open Cupping TherapyWho was studied
- People with a condition
- Ankylosing Spondylitis
- Gout
- Osteoarthritis
- Psoriasis
- Rheumatoid Arthritis
- Scleroderma
- +1 more
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Vasculitis worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Vasculitis is a condition within the immune-health category. Its classification provides a framework for understanding where it fits, while surrounding information offers essential context. Individual questions about this medical condition are best discussed with a qualified clinician.
Evidence-backed options
No evidence-backed options are listed here for Vasculitis. Because Vasculitis is a medical condition, treatment and management decisions should be discussed with a qualified clinician.
What to avoid
Iodine is flagged for avoidance in vasculitis because potassium iodide can provoke serious systemic hypersensitivity reactions in people with hypocomplementemic urticarial vasculitis. This concern relates to the potential for a widespread reaction in this specific vasculitis context, rather than being a general statement about every form or use of iodine.
Because potassium iodide is contraindicated in hypocomplementemic urticarial vasculitis, the relevance of an iodine-containing product depends on its form and ingredients. Anyone with vasculitis should review iodine or potassium iodide products with a clinician before use, particularly when the diagnosis is hypocomplementemic urticarial vasculitis.